About The END Fund

The END Fund is a private philanthropic initiative to combat the five most common neglected tropical diseases (NTDs) that, together, cause up to 90% of the NTD burden in sub-Saharan Africa. Supported by a group of global philanthropists, the END Fund provides financing for nationwide disease control initiatives, creating new programs, supplementing existing ones, and using leveraged funds to extend and deepen the impact.

The END Fund provides exceptional return on investment by harnessing the highly scalable impact of low-cost mass drug administrations.

website icon
Website
employees icon
Employees
industry icon
Industry
Philanthropy
location icon
Location
2 Park Avenue, 18th Floor, New York, NY 11238, US
description icon
Founded
2012
description icon
Keywords
Neglected Tropical Diseases And Impact Philanthropy

The END Fund Alternatives

Frequently Asked Questions about The END Fund

Who is the CEO of The END Fund?

Ellen Agler is the CEO of The END Fund. To contact Ellen Agler email at [email protected].

Who are the decision makers in The END Fund?

The decision makers in The END Fund are Carol Karutu, Diana Benton Schechter, Ellen Agler, etc. Click to Find The END Fund decision makers emails.

What are neglected tropical diseases (NTDs) and why are they important?

Neglected tropical diseases (NTDs) are a group of infectious diseases that primarily affect the world's poorest populations. They include diseases such as lymphatic filariasis, schistosomiasis, and river blindness, among others. NTDs are important to address because they can cause severe health issues, disability, and even death, while also contributing to poverty and social stigma. The END Fund focuses on combating these diseases to improve health outcomes and enhance the quality of life for affected communities.

How does The END Fund contribute to the fight against NTDs?

The END Fund works by providing funding and support for programs that deliver preventive treatments, improve health systems, and conduct research on neglected tropical diseases. The organization collaborates with local governments, NGOs, and healthcare providers to implement effective strategies for disease control and elimination, ensuring that resources are directed where they are most needed.

What types of solutions does The END Fund offer to combat NTDs?

The END Fund offers a range of solutions including mass drug administration (MDA) campaigns, health education initiatives, and capacity-building programs for local health systems. By focusing on prevention, treatment, and education, The END Fund aims to reduce the incidence of NTDs and empower communities to take charge of their health.

Which regions and populations does The END Fund serve?

The END Fund primarily focuses on sub-Saharan Africa, where the burden of neglected tropical diseases is highest. The organization targets vulnerable populations, including children and those living in impoverished communities, to ensure that interventions reach those most at risk of NTDs.

How can individuals and organizations get involved with The END Fund?

Individuals and organizations can get involved with The END Fund by making a donation, fundraising, or raising awareness about neglected tropical diseases. The END Fund also welcomes partnerships with businesses and philanthropic organizations that share a commitment to improving global health and combating NTDs.

What impact has The END Fund made since its inception?

Since its inception, The END Fund has made significant strides in the fight against neglected tropical diseases. The organization has supported millions of treatments, contributed to the strengthening of health systems, and helped to raise awareness about the importance of addressing NTDs. Through collaborative efforts, The END Fund has played a crucial role in reducing the prevalence of these diseases in affected communities.

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more